1982 Study In Medical Journal Cancer
Recent talcum powder cancer lawsuit news hasn't heavily featured a 1982 study that found a considerable link between talcum powder and an increased risk in the contraction of ovarian cancer.
Monday, December 28, 2015 - In July of 1982, a study was published in the medical journal Cancer that found a correlation between the use of talcum powder by women and an increase in their risk for contracting ovarian cancer. The study occurred early in the timeline for talcum powder research as it related to cancer, as barely a decade before the first recognized study was conducted in Britain that began the investigation into the connection between cancer and women's use of the drug genitally. Those allegations are now the base of hundreds of lawsuits currently pending against manufacturer Johnson & Johnson that have inspired talcum powder cancer lawsuit news around the country
The case study presenting in Cancer looked at 215 women that were diagnosed with cancer in Boston between November 1978 and September 1981. 43 of the women who contracted ovarian cancer claimed that they used talcum powder perennially, compared to a control group of a similar background in the study where only 28 percent claimed to have regularly used talcum powder. The study was quite small, and its principal author called for further study into the link beyond the results of the study.
The plaintiffs in the talcum powder lawsuits claim that defendants Johnson & Johnson, Imerys Talc America and Walgreens were all at fault in manufacturing and selling talcum powder that is allegedly linked to ovarian cancer. The plaintiffs have referenced a number of studies conducted as far back as 1973 that link talcum powder to a higher risk of ovarian cancer.
The studies have demonstrated that when used regularly, talcum powder can travel up a woman's vaginal tract to the ovaries, where they can contribute to the development of ovarian cancer. Talcum powder used to contain asbestos until the FDA outlawed the ingredient in the powders in 1973. Plaintiffs claim however that talcum powder still has cancer-causing particles and its lack of regulation by the FDA has led to consumers around the country contracting ovarian cancer caused by their regular talcum powder use.
Citing years of talcum powder ovarian cancer lawsuit news and decades of studies performed investigating the link between talcum powder and ovarian cancer, the plaintiffs are claiming that the defendants failure to warn consumers of the potential dangers of the product was illegal. Some studies, including one performed by the medical journal Cancer Prevention Research, have found that regular talcum powder use by women can increase the risk of ovarian cancer by up to 30 percent. Plaintiffs claim that these risks were ignored by the manufacturers in an attempt to continue to market the product free of the deadly associations with cancer.
Lawsuits around the country have been filed on similar claims, with a majority of those suits occurring in New Jersey and St. Louis. More than 100 cases in New Jersey, where Johnson & Johnson is headquartered, were recently consolidated into multicounty litigation before a single judge as the number of claims were becoming excessive to litigate in their individual districts. More lawsuits are expected to be filed around the country as well as talcum powder lawsuit news of the link between talcum powder and ovarian cancer spreads.